MedPath

Short Term Comparative Study of Xalatan With Benzalkonium Chloride vs. Travatan Z Without Benzalkonium Chloride in Healthy Volunteers

Phase 4
Completed
Conditions
Glaucoma
Registration Number
NCT00468988
Lead Sponsor
Alcon Research
Brief Summary

Compare the effect of Xalatan with benzalkonium chloride on the ocular surface to those effects observed with Travatan Z without benzalkonium chloride after a single dose

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Adults with primary open-angle glaucoma, ocular hypertension or pigment dispersion glaucoma
Exclusion Criteria
  • Age

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Tear Break Up TimeDay
Secondary Outcome Measures
NameTimeMethod
SafetyOnset

Trial Locations

Locations (1)

Orlando

🇺🇸

Orlando, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath